Privacy Policy introduced on 25th of May 2018

On May 25, 2018, the European Union will begin to enforce more strict privacy rules under the General Data Protection Regulation (GDPR), which applies to companies globally that offer goods and services to European Union residents. To ensure we are providing you with the latest documentation about how we collect, use, share and secure your information, we want to make you aware of our updated privacy policy.

We value your trust and appreciate the opportunity to share this update with you.

Go back

News

Phase IIa diabetes study termination

We have succesfully completed phase II study for patients suffered from diabetes type II.

Read more …

Rivaroxaban bioequivalence studies

Our site has completed 5 bioequivalence studies with Rivaroxaban. The studies were conducted in our 1st phase unit in Kajetany.

Read more …

Clinical study with cladribine completed

We have succesfully completed phase I study for female patients suffering from multiple sclerosis.

Read more …

31st Great Final of WOŚP

31st Great Final of Wielka Orkiestra Świątecznej Pomocy.

Lets play till the end of the world and one day longer!

Read more …

Merry Christmas

We wish you Merry Christmas and Happy New Year!

Read more …

About Us | Services | Our Site | Partners | Smoking Risk Study | Contact Us

Early Phase Clinical Trials

2025 © Bio Research Group. All rights reserved.

 

scroll to top ▲